Media coverage
3
Media coverage
Title High-Dose Imetelstat Could Offer Patients with High-Risk Myelofibrosis Improved Overall Survival Media name/outlet CURE Magazine Country/Territory United States Date 5/12/20 URL https://www.curetoday.com/view/high-dose-imetelstat-could-offer-patients-with-high-risk-myelofibrosis-improved-overall-survival Persons John Mascarenhas Title High-Dose Imetelstat Improves Overall Survival and Offers Clinical Benefits in High-Risk Myelofibrosis Media name/outlet OncLive Country/Territory United States Date 5/12/20 URL https://www.onclive.com/view/high-dose-imetelstat-improves-overall-survival-and-offers-clinical-benefits-in-high-risk-myelofibrosis Persons John Mascarenhas Title High-Dose Imetelstat Improves OS, Offers Clinical Benefit in High-Risk Myelofibrosis Media name/outlet Cancernetwork.com Country/Territory United States Date 5/12/20 URL https://www.cancernetwork.com/view/high-dose-imetelstat-improves-os-offers-clinical-benefit-in-high-risk-myelofibrosis Persons John Mascarenhas